Erythrocytosis after SGLT2 inhibitor initiation and anticoagulated outcomes in atrial fibrillation: a real-world analysis with counterfactual modeling @livhp.bsky.social @livuniresearch.bsky.social #Afib link.springer.com/article/10.1...
link.springer.com
Erythrocytosis after SGLT2 inhibitor initiation and anticoagulated outcomes in atrial fibrillation: a real-world analysis with counterfactual modeling - Cardiovascular Diabetology
Cardiovascular Diabetology - Erythrocytosis has emerged as a hematologic response to sodium–glucose cotransporter 2 (SGLT2) inhibitor therapy, yet its occurrence and potential impact on...